Table 2 Absolute reduction in confirmed cases during the pandemic period (week 12–39)
From: Gender disparities in access to care for time-sensitive conditions during COVID-19 pandemic in Chile
Men Count (95%CI) | Women Count (95%CI) | Excess impact on woman Count (95%CI) | |
|---|---|---|---|
All cardiovascular diseases | 9,047 (6,845 - 11,248) | 10,315 (7,791 - 12,838) | 1,268 (946–1,590) |
Stroke (includes transient ischemic attack) | 1,557 (798–2,214) | 2,286 (1,428–3,144) | 729 (631–930) |
Myocardial infarction | 7,497 (5,702 - 8,906) | 8,035 (5,952 - 9,529) | 538 (250–624) |
All cancer | 2,056 (611–3,161) | 11,196 (5,229 - 17,163) | 9,140 (4,619 - 13,661) |
All cancer (excluding sex specific cancer) | 1,863 (564–3,161) | 3,215 (1,307 - 5,122) | 1,352 (743–1,961) |
Gastric cancer | 828 (44–1,612) | 1,390 (406–2,374) | 562 (362–762) |
Colorectal cancer | 896 (348–1,444) | 1,740 (636–2,844) | 844 (288–1,401) |
Lymphoma | 128 (− 25–281) | 111 (− 36–258) | 17 (11–23) |
Leukemia | 10 (− 20–40) | 15 (− 44–13) | -5 (−4 - -7) |
Cervical cancer (includes dysplasia) | .. | 5,185 (2,522 - 7,848) | .. |
Breast cancer | .. | 2,931 (784–5,078) | .. |
Testicular cancer | 202 (−25–430) | .. | .. |